Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Avoid Kooth (KOO) by Steve Moore in ShareProphets
- Buy Chesnara (CSN) by Tom Winnifrith in ShareProphets
- Buy Chesnara (CSN) by Steve Moore in ShareProphets
- Hold Playtech (PTEC) by Jefferies
- Hold Great Portland Estates (GPE) by Jefferies
- Buy Foresight Group Holdings Limited NPV (FSG) by Jefferies
- Avoid Aptitude Software Group (APTD) by Steve Moore in ShareProphets
- Buy Devolver Digital, Inc. (DI) Reg S Cat 3/144A (DEVO) by Shore Capital
- Avoid Solid State (SOLI) by Steve Moore in ShareProphets
- Buy Thor Explorations Ltd (DI) (THX) by Canaccord Genuity
- Buy Berkeley Group Holdings (The) (BKG) by Bank of America
- Buy On The Beach Group (OTB) by Deutsche Bank
- Buy Motorpoint Group (MOTR) by Deutsche Bank
- Sector Perform Advanced Medical Solutions Group (AMS) by RBC Capital
- Neutral Rightmove (RMV) by Citi
- Neutral WPP (WPP) by Citi
- Buy Relx plc (REL) by Citi
- Sell BT Group (BT.A) by UBS
- Neutral Auto Trader Group (AUTO) by Citi
- Neutral Informa (INF) by Citi
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 23 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 10.00p | Latest Ask : 11.00p |
| High Today : 11.00p | Low Today : 10.00p |
| This Years High : 12.10p | This Years Low : 5.25p |
| Volume : 178,083 | MKT Cap : £505.2M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2019-06-28 10:20:00 28/06/2019 | – |
| Corporate | FinnCap | Premium Only | 2019-03-22 10:10:00 22/03/2019 | – |
| Hold | Tempus Editors | Premium Only | 2019-03-19 00:05:00 19/03/2019 | 192.45% |
| Corporate | FinnCap | Premium Only | 2019-03-06 09:25:00 06/03/2019 | – |
| Buy | Numis | Premium Only | 2018-09-26 08:30:00 26/09/2018 | -47.55% |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10.00p | Latest Ask : 11.00p |
| High Today : 11.00p | Low Today : 10.00p |
| This Years High : 12.10p | This Years Low : 5.25p |
| Volume : 178,083 | MKT Cap : £505.2M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Corporate | FinnCap | Premium Only | 2019-06-28 10:20:00 28/06/2019 | – |
| Corporate | FinnCap | Premium Only | 2019-03-22 10:10:00 22/03/2019 | – |
| Hold | Tempus Editors | Premium Only | 2019-03-19 00:05:00 19/03/2019 | 192.45% |
| Corporate | FinnCap | Premium Only | 2019-03-06 09:25:00 06/03/2019 | – |
| Buy | Numis | Premium Only | 2018-09-26 08:30:00 26/09/2018 | -47.55% |